CAT vs NMRA · P/E 48, rev $37.96B vs $283.5M cap
Caterpillar Inc (CAT) versus Neumora Therapeutics, Inc. (NMRA) — a side-by-side from cached financials, not a winner call.
Caterpillar Inc (CAT) is a farm & heavy construction machinery company listed on NYSE. It is led by Jim Umpleby.
Neumora Therapeutics, Inc. (NMRA) is a biotechnology company listed on NASDAQ.
Latest reported CAT revenue for 2026-06-30 was $37.96B. Net income was $6.14B. CAT currently screens at market cap $440.29B and trailing P/E 47.7.
NMRA does not have a complete income-statement cache yet.
CAT currently screens at market cap $440.29B and trailing P/E 47.7. NMRA currently screens at market cap $283.5M.
Not investment advice. Open the CAT and NMRA stock pages for the full models.
Not investment advice.